Related Experiment Videos
alpha 1 Antitrypsin (PI) allotypes in rheumatoid arthritis
Annals of the Rheumatic Diseases
|June 1, 1986
Summary
This study found no link between alpha 1 Antitrypsin (PI) variants and rheumatoid arthritis (RA) severity. However, the PI M1M2 phenotype was more common in RA patients, suggesting a potential genetic predisposition.
Area of Science:
- Genetics
- Immunology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease.
- Genetic factors are known to influence RA susceptibility.
- Alpha 1 Antitrypsin (PI) is a protein with known genetic variants.
Purpose of the Study:
- To investigate the association between alpha 1 Antitrypsin (PI) phenotypes and rheumatoid arthritis (RA).
- To determine if PI allotypes correlate with disease severity or autoantibody levels in RA patients.
Main Methods:
- Phenotyping of alpha 1 Antitrypsin (PI) in 144 RA patients and 223 healthy controls.
- Analysis of PI variant frequencies (F, S, Z, M1M2) in both groups.
- Correlation analysis between PI allotypes and RA disease parameters (severity, autoantibody titre).
Main Results:
- Frequencies of rare PI variants (F, S, Z) were comparable between RA patients and controls.
- No significant association was found between PI allotypes and RA disease severity or autoantibody titre.
- The PI M1M2 phenotype showed an increased frequency in the RA group compared to controls.
Conclusions:
- The PI M1M2 phenotype may be a genetic marker associated with rheumatoid arthritis.
- These findings suggest that genes on chromosome 14, linked to PI, might predispose individuals to RA.
- Further research is warranted to elucidate the specific genetic mechanisms involved.